Unifire Signs Agreement with Best-In-Class Cybersecurity Tech Company to Support President Biden’s Call for Stronger Cyber Defense

Exclusive Distribution Agreement with QRC Americas SA Provides Innovative Digital Security Solutions Against Quantum Computers Attacks

SPOKANE, WASHINGTONMARCH 31, 2022 – Unifire, Inc., a wholly-owned subsidiary of Mission Ready Solutions Inc. (“Mission Ready“) (TSX Venture: MRS) (OTCQX: MSNVF), proudly announces that it has entered into an exclusive distribution agreement with QRC Americas SA (QRCrypto) for their quantum-safe cryptography solutions and other related technologies. As part of the agreement, Unifire has been granted exclusive rights to distribute QRCrypto’s leading-edge cybersecurity solutions to the U.S. Government.

The dramatic increase in cyberterrorism, the rise of 5G advanced wireless resulting in millions of vulnerable new endpoints for data transmission and storage, and the reality of powerful quantum computers emerging years before originally predicted are creating a new urgency for protection of data and networks.

“QRCrypto is a world-leader in quantum-safe cryptography and offers the most advanced solution on the market with its potential to revolutionize the cyber defense landscape,” said Dan Raczykowski, Chief Operating Officer of Unifire. “Commercially available quantum computers have the capacity to crack code and break cryptography systems widely adopted among government agencies faster than anything we have seen before.”

QRCrypto offers efficient solutions to keep digital communications safe that include software and SIM cards compatible with existing server infrastructure, drastically reducing the cost of implementation. Their unique quantum-safe technology in 5G systems is the only solution recommended by the United Nations International Telecommunication Union.

Mission Ready Chairman and Major General (Retired) James “Spider” Marks commented, “President Biden’s recent speeches emphasized the importance of stronger defenses against cyberterrorism amid international political tensions. We have seen a significant increase in countries and governments facing cyberattacks, putting some of the world’s largest IT infrastructures at risk. With IT being at the center of today’s warfare, solutions that can withstand present-day and next-generation attacks could be decisive factors in a country’s capacity to respond to cyberterrorism. Early adoption for U.S. institutions could have game-changing effects on their security solutions and allow them to prepare for potential privacy and security disasters.”

“Because of Unifire’s rich experience as a trusted solution provider to U.S. federal, state, and local government, we are very proud to have them as QRCrypto’s exclusive distributor in this space,” said Stiepan Kovac, Co-founder and CEO of QRCrypto. “With QRCrypto, Unifire can now help U.S. government entities protect themselves against current classical and next-generation cyberterrorism threats, including quantum attacks.”

 

Due to the highly specialized nature of this product, please enter your contact information below for more information and we will reach out to you directly.




About Unifire Inc.

Unifire, Inc. specializes in providing top-performing products, training, and solutions to military, fire rescue, and law enforcement worldwide and ensuring mission success. With extensive knowledge and experience in providing turnkey solutions to the United States Federal Government, Unifire leverages its robust vendor network, time-proven industry relationships and proprietary technology infrastructure and industry-leading manufacturing and distribution capabilities to efficiently source and deliver mission-critical, life-saving products in cooperation with government program managers, military and federal contracting offices, base supply centers, and other federal, state and local supply agencies.

For further information on Unifire, Inc., visit UnifireUSA.com. You can also subscribe to our mailing list at eepurl.com/hzut7z to receive our press releases and latest news directly by email.


Media Contact
Inquiries@UnifireUSA.com
+1 877.479.7778 (Ext. 5).

Unifire, Inc.
(Signed “Skip Church”)
Skip Church
President
T: +1 509.535.7746

Forward-Looking Disclaimer

This press release contains certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward‐looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward‐looking statements. No assurance can be given that these expectations will prove to be correct and such forward‐looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.

Forward‐looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Unifire’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Unifire undertakes no obligation to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Unifire to predict or assess the impact of each such factor or the extent to which any factor, or combination thereof, may cause results to differ materially from those contained in any forward‐looking statement. Any forward‐looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

Unifire, Inc. and NuGen M.D. enter into Master Distribution and Marketing Agreement for Leading-Edge Needle-Free Injection Device

Unifire to Focus on Distribution to Government Agencies and Humanitarian Efforts

VANCOUVER, BRITISH COLUMBIA, CANADA – MARCH 22, 2022 – Mission Ready Solutions Inc (“Mission Ready” or the “Company“) (TSX-V: MRS) (OTCQX: MSNVF) (FSE: 2R4), a provider of comprehensive government contracting solutions, is pleased to announce that, through its wholly-owned subsidiary, Unifire, Inc. (“Unifire“), the Company has entered into a Master Distribution and Marketing Agreement (the “Agreement“) with NuGen M.D. (TSX-V: NGMD) (“NuGen“), an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies.

As part of the Agreement, Unifire has been granted exclusive rights to sell NuGen’s needle-free injection device InsuJet™ into various US Government agencies and non-exclusive rights to sell into  Government agencies in Israel and Australia. Unifire will act as NuGen’s Master Distributor in the United States with an immediate focus on opportunities within the Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), Defense Advanced Research Projects Agency (DARPA), Veterans Affairs (VA), Department of Homeland Security (DHS) and Health and Human Services (HHS).

NuGen InsuJet™ needleless injection system is a revolutionary needle-free way to inject medication or vaccines and:

  • Provides faster absorption of medicine than hypodermic needles
  • Reduces fear and anxiety associated with hypodermic needles
  • Eliminates needlestick injuries
  • Reduces the risk of cross-contamination and infections
  • Reduces cost burdens on the health care system
  • Reduces cost for patients
  • Reduces biohazard waste

 

“We are thrilled to have Unifire join our worldwide network of distributors with their deep understanding of the government contracting space, proven relationships, and track record of execution,” stated Michael Wright, CEO of NuGen. “Unifire will support NuGen in carrying out its expansion strategy in the US market by focusing on gaining acceptance for InsuJet™ as a safe, reliable and cost-effective replacement solution for current medication injection standard within Unifire’s well-established clientele of government agencies.”

Unifire will collaborate with NuGen to seek regulatory approval, garner political support, introduce non-dilutive government funding, while advising on the necessary manufacturing and supply chain requirements to be eligible to submit to government RFPs.

“A device with the demonstrated ability to safely, rapidly and effectively deliver critical medication has the potential to create a paradigm shift in the current standard of care in place within government agencies,” said Douglas Bryce, Advisory Committee member for Mission Ready and subject matter expert on development, acquisition, distribution, and deployment of Chemical, Biological, Radiological, and Nuclear (CBRN) defense devices and medical diagnostic systems, drugs and vaccines. “I strongly believe there are significant opportunities to deploy new and disruptive solutions within the Department of Defense, government-operated medical facilities, and their adoption into Tactical Combat Casualty Care.”

Jointly, the Companies will focus on opportunities within:

  • Immediate Humanitarian Efforts to Provide Safe Access to Insulin treatments
  • Global Vaccination Efforts
  • Biomedical Advanced Research and Development Authority (BARDA)
  • Defense Advanced Research Projects Agency (DARPA)
  • Veterans Affairs (VA) for acceptance to support healthcare requirements
  • DoD or government agencies with medical facilities
  • Inclusion in Tactical Combat Casualty Care (TCCC)

Dan Raczykowski, Chief Operating Officer of Unifire, added, “Unifire prides itself in delivering best-in-class technologies that can provide solutions to critical needs. NuGen’s needle-free device, with its regulatory approval in more than 40 countries, could open new opportunities within our network, particularly in these times of need for humanitarian relief where access to life-saving medication represents a logistical challenge for certain populations. We are excited to join NuGen’s global distributor list while supporting their team on their path towards US regulatory approval.”

About the InsuJet™

The InsuJet™ is a revolutionary needle-free drug delivery device used to self-administer medication in a safe, fear-free, and virtually pain-free manner and is now approved for use in over 40 countries globally.

About NuGen Medical Devices

NuGen Medical Devices’ principal business is the development and commercialization of innovative needle-free injection devices and systems for subcutaneous medication administration.

It is developing products using needle-free drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis as well as DNA and conventional/pediatric vaccines.

About Mission Ready Solutions Inc.

Mission Ready Solutions provides comprehensive government contracting solutions with extensive experience in delivering quality, reliable, mission-critical products and services for law enforcement, firefighters, first responders, military, and other governmental agencies.

Through its privileged access to a host of federal contracting vehicles, including Multiple Award Schedule (“MAS“) contracts awarded and administered by the United States General Services Administration, Mission Ready’s wholly-owned subsidiary, Unifire, Inc., leverages its robust vendor network, time-proven industry relationships, proprietary technology infrastructure, and industry-leading manufacturing and distribution capabilities to efficiently source and deliver more than 1.5 million products.

For further information on Mission Ready Solutions Inc., please visit MRSCorp.com.
You can also subscribe to our mailing list at eepurl.com/hznhX9 to receive our press releases and latest news directly by email.

Mission Ready Solutions Inc.

(Signed “Buck L. Marshall”)

Buck L. Marshall
President, CEO and Director
T: +1 877.479.7778

 

Investor Relations Contact:

Dominic Gray
MRS-IR@MRSCorp.com
T: +1 877.479.7778 (Ext.5)

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “forecast”, “project”, “budget”, “schedule”, “may”, “will”, “could”, “might”, “should” or variations of such words or similar words or expressions. Forward-looking information is based on reasonable assumptions that have been made by Mission Ready Solutions Inc. as at the date of such information and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Mission Ready Solutions Inc. to be materially different from those expressed or implied by such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Mission Ready Solutions Inc. does not undertake to update any forward-looking information that is included herein, except in accordance with applicable securities laws.